Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Mar;65(3):285-93.
doi: 10.1136/ard.2005.038638. Epub 2005 Aug 17.

Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data

J A P Da Silva  1 , J W G Jacobs, J R Kirwan, M Boers, K G Saag, L B S Inês, E J P de Koning, F Buttgereit, M Cutolo, H Capell, R Rau, J W J Bijlsma
Affiliations
Review

Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data

J A P Da Silva et al. Ann Rheum Dis. 2006 Mar.

Abstract

Adverse effects of glucocorticoids have been abundantly reported. Published reports on low dose glucocorticoid treatment show that few of the commonly held beliefs about their incidence, prevalence, and impact are supported by clear scientific evidence. Safety data from recent randomised controlled clinical trials of low dose glucocorticoid treatment in RA suggest that adverse effects associated with this drug are modest, and often not statistically different from those of placebo.

PubMed Disclaimer

Conflict of interest statement

Competing interest: None.

References

    1. Kirwan J R. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low‐Dose Glucocorticoid Study Group. N Engl J Med 1995333142–146. - PubMed
    1. Hickling P, Jacoby R K, Kirwan J R. Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group. Br J Rheumatol 199837930–936. - PubMed
    1. Wassenberg S, Rau R, Steinfeld P, Zeidler H. Very low‐dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double‐blind, placebo‐controlled trial. Arthritis Rheum 2005523371–3380. - PubMed
    1. van Everdingen A A, Jacobs J W, Siewertsz van Reesema D R, Bijlsma J W. Low‐dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease‐modifying properties, and side effects: a randomized, double‐blind, placebo‐controlled clinical trial. Ann Intern Med 20021361–12. - PubMed
    1. Capell H A, Madhok R, Hunter J A, Porter D, Morrison E, Larkin J.et al Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial. Ann Rheum Dis 200463797–803. - PMC - PubMed

MeSH terms